| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.882 | |
| heart contraction | GO:0060047 | 93 | 0.849 | |
| muscle system process | GO:0003012 | 141 | 0.828 | |
| regulation of system process | GO:0044057 | 200 | 0.751 | |
| striated muscle contraction | GO:0006941 | 45 | 0.714 | Zebrafish |
| muscle contraction | GO:0006936 | 101 | 0.670 | |
| heart process | GO:0003015 | 94 | 0.626 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.618 | Worm |
| actin filament based movement | GO:0030048 | 23 | 0.582 | Human |
| circulatory system process | GO:0003013 | 197 | 0.579 | |
| skeletal muscle adaptation | GO:0043501 | 16 | 0.562 | |
| muscle cell development | GO:0055001 | 133 | 0.503 | |
| muscle adaptation | GO:0043500 | 39 | 0.487 | |
| heart morphogenesis | GO:0003007 | 178 | 0.485 | |
| myofibril assembly | GO:0030239 | 34 | 0.459 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.456 | |
| muscle tissue development | GO:0060537 | 308 | 0.450 | |
| sarcomere organization | GO:0045214 | 24 | 0.450 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.433 | |
| skeletal myofibril assembly | GO:0014866 | 4 | 0.413 | Fly |
| organelle assembly | GO:0070925 | 177 | 0.411 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.396 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.396 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.362 | |
| striated muscle cell development | GO:0055002 | 125 | 0.344 | |
| regulation of skeletal muscle adaptation | GO:0014733 | 12 | 0.311 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.311 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.305 | Worm |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.300 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.260 | Worm |
| striated muscle tissue development | GO:0014706 | 293 | 0.249 | |
| muscle filament sliding | GO:0030049 | 1 | 0.244 | Human |
| blood circulation | GO:0008015 | 195 | 0.236 | |
| skeletal muscle thin filament assembly | GO:0030240 | 2 | 0.235 | Fly |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.233 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.231 | |
| response to inorganic substance | GO:0010035 | 96 | 0.212 | Human |
| cardiac chamber development | GO:0003205 | 108 | 0.173 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.159 | |
| transition between fast and slow fiber | GO:0014883 | 9 | 0.147 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.139 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.137 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.121 | Fly |
| myosin filament organization | GO:0031033 | 3 | 0.121 | Worm |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.121 | Fly |
| transmembrane transport | GO:0055085 | 412 | 0.120 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.115 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.113 | Human |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.110 | Fly |
| striated muscle adaptation | GO:0014888 | 26 | 0.105 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.104 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.103 | Fly |
| myosin filament assembly | GO:0031034 | 2 | 0.103 | Worm |
| cardiocyte differentiation | GO:0035051 | 87 | 0.101 | |
| response to oxidative stress | GO:0006979 | 123 | 0.100 | |
| maintenance of location | GO:0051235 | 89 | 0.093 | Worm |
| cell adhesion | GO:0007155 | 329 | 0.092 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.090 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.089 | Human |
| cation transport | GO:0006812 | 399 | 0.088 | |
| defecation | GO:0030421 | 1 | 0.087 | |
| cardiac cell development | GO:0055006 | 41 | 0.083 | |
| cation homeostasis | GO:0055080 | 212 | 0.082 | Fly |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.082 | |
| actin myosin filament sliding | GO:0033275 | 1 | 0.082 | Human |
| actin filament organization | GO:0007015 | 113 | 0.082 | Fly |
| myotube differentiation | GO:0014902 | 105 | 0.079 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.077 | |
| cellular homeostasis | GO:0019725 | 240 | 0.077 | Fly |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.077 | Human |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.077 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.075 | |
| muscle fiber development | GO:0048747 | 76 | 0.074 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.073 | Human |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.072 | Fly |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.072 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.071 | |
| regulation of cell motility | GO:2000145 | 236 | 0.071 | |
| lung development | GO:0030324 | 164 | 0.071 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.070 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.069 | Human |
| respiratory system development | GO:0060541 | 190 | 0.066 | |
| organelle fission | GO:0048285 | 170 | 0.065 | |
| regulation of atp catabolic process | GO:1903289 | 9 | 0.064 | Human |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.063 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.062 | |
| response to hypoxia | GO:0001666 | 58 | 0.062 | |
| lipid localization | GO:0010876 | 126 | 0.061 | Worm |
| amine metabolic process | GO:0009308 | 45 | 0.060 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.059 | Human |
| negative regulation of potassium ion transmembrane transporter activity | GO:1901017 | 3 | 0.059 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.058 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.058 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.058 | |
| respiratory tube development | GO:0030323 | 167 | 0.058 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.057 | Fly |
| mitochondrion organization | GO:0007005 | 134 | 0.056 | Fly |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.054 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.054 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.054 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.053 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.053 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.052 | Human |
| sequestering of calcium ion | GO:0051208 | 18 | 0.052 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.051 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.050 | Human |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.050 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.050 | |
| epithelial cell development | GO:0002064 | 159 | 0.050 | |
| regulation of heart rate | GO:0002027 | 36 | 0.049 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.048 | Human |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.048 | |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0014808 | 12 | 0.048 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.048 | Human |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.048 | |
| histone modification | GO:0016570 | 159 | 0.046 | |
| wound healing | GO:0042060 | 157 | 0.046 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.045 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.045 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.045 | |
| camera type eye development | GO:0043010 | 266 | 0.045 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.045 | |
| endomembrane system organization | GO:0010256 | 147 | 0.045 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.045 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.044 | Human |
| gonad development | GO:0008406 | 141 | 0.043 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.043 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.043 | |
| locomotory behavior | GO:0007626 | 195 | 0.043 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.043 | |
| long chain fatty acid import | GO:0044539 | 2 | 0.042 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.042 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.041 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.041 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.041 | Human |
| axonogenesis | GO:0007409 | 274 | 0.041 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.040 | |
| angiogenesis | GO:0001525 | 201 | 0.039 | Zebrafish |
| response to oxygen levels | GO:0070482 | 62 | 0.038 | |
| regulation of ion transport | GO:0043269 | 215 | 0.038 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.038 | Worm |
| tubulin complex biogenesis | GO:0072668 | 2 | 0.038 | |
| lipid storage | GO:0019915 | 36 | 0.036 | Worm |
| regulation of intracellular transport | GO:0032386 | 159 | 0.036 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.036 | |
| nuclear division | GO:0000280 | 158 | 0.036 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.036 | Human |
| response to radiation | GO:0009314 | 165 | 0.036 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.035 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.035 | Human |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.035 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.035 | |
| regulation of skeletal muscle contraction | GO:0014819 | 3 | 0.035 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.035 | Human |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.035 | |
| action potential | GO:0001508 | 78 | 0.034 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.034 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.034 | Human |
| fatty acid metabolic process | GO:0006631 | 121 | 0.034 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.034 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.034 | Zebrafish |
| nucleotide metabolic process | GO:0009117 | 332 | 0.034 | Human |
| organic anion transport | GO:0015711 | 137 | 0.033 | |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | GO:0010880 | 10 | 0.033 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.033 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.033 | Fly |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.033 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.033 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.033 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.033 | Human |
| potassium ion transport | GO:0006813 | 52 | 0.033 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.033 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.032 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.032 | |
| microtubule based process | GO:0007017 | 236 | 0.032 | |
| cellular response to inorganic substance | GO:0071241 | 37 | 0.032 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.032 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.031 | |
| skeletal system development | GO:0001501 | 356 | 0.031 | |
| oxidation reduction process | GO:0055114 | 342 | 0.031 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.031 | Fly |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.031 | Human |
| organophosphate catabolic process | GO:0046434 | 232 | 0.031 | Human |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.030 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.030 | |
| tube formation | GO:0035148 | 140 | 0.030 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.030 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.030 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.030 | Human |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.030 | Human |
| ossification | GO:0001503 | 216 | 0.030 | |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | GO:0010881 | 7 | 0.029 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.029 | Human |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.029 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.029 | |
| skin development | GO:0043588 | 220 | 0.029 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.029 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.029 | |
| chemotaxis | GO:0006935 | 247 | 0.028 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.028 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.028 | Human |
| regulation of body fluid levels | GO:0050878 | 162 | 0.028 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.028 | Human |
| carboxylic acid transport | GO:0046942 | 100 | 0.028 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.028 | Human |
| muscle cell cellular homeostasis | GO:0046716 | 12 | 0.028 | Fly |
| regulation of actin filament based process | GO:0032970 | 99 | 0.027 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.027 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.027 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.027 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.027 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.027 | Human |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.027 | Human |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.027 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.027 | Human |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.027 | Human |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.026 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.026 | |
| anion transport | GO:0006820 | 177 | 0.026 | |
| positive regulation of growth | GO:0045927 | 104 | 0.026 | |
| atp catabolic process | GO:0006200 | 55 | 0.026 | Human |
| response to organic cyclic compound | GO:0014070 | 198 | 0.026 | |
| directional locomotion | GO:0033058 | 3 | 0.026 | |
| regulation of phosphatidylcholine biosynthetic process | GO:2001245 | 2 | 0.026 | |
| endoplasmic reticulum to cytosol transport | GO:1903513 | 12 | 0.026 | |
| lung alveolus development | GO:0048286 | 45 | 0.026 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.026 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.026 | Human |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.026 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.026 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.026 | Human |
| response to muscle stretch | GO:0035994 | 1 | 0.026 | |
| cell fate commitment | GO:0045165 | 210 | 0.026 | |
| calcium ion transport from endoplasmic reticulum to cytosol | GO:1903514 | 12 | 0.025 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.025 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.025 | Human |
| potassium ion homeostasis | GO:0055075 | 4 | 0.025 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.025 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.025 | |
| regulation of binding | GO:0051098 | 111 | 0.025 | |
| developmental maturation | GO:0021700 | 193 | 0.025 | |
| feeding behavior | GO:0007631 | 62 | 0.025 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.025 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.025 | |
| glucose metabolic process | GO:0006006 | 92 | 0.025 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.025 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.025 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.024 | Worm |
| cell growth | GO:0016049 | 130 | 0.024 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.024 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.024 | |
| dna metabolic process | GO:0006259 | 303 | 0.024 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.024 | |
| placenta development | GO:0001890 | 140 | 0.024 | |
| cartilage development | GO:0051216 | 140 | 0.024 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.024 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.024 | Human |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.024 | Human |
| regulation of sarcomere organization | GO:0060297 | 4 | 0.024 | |
| regulation of atp metabolic process | GO:1903578 | 17 | 0.024 | Human |
| nucleoside catabolic process | GO:0009164 | 206 | 0.024 | Human |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.024 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.023 | |
| forebrain development | GO:0030900 | 302 | 0.023 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.023 | Human |
| nucleotide catabolic process | GO:0009166 | 217 | 0.023 | Human |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.023 | |
| oocyte construction | GO:0007308 | 2 | 0.023 | |
| amide transport | GO:0042886 | 138 | 0.023 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.023 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.023 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.023 | |
| hormone metabolic process | GO:0042445 | 86 | 0.023 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.023 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.023 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.023 | Human |
| t cell proliferation | GO:0042098 | 120 | 0.023 | |
| regulation of cell migration | GO:0030334 | 219 | 0.023 | |
| negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway | GO:1902176 | 4 | 0.022 | |
| response to growth factor | GO:0070848 | 198 | 0.022 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.022 | |
| regulation of atpase activity | GO:0043462 | 9 | 0.022 | Human |
| sa node cell action potential | GO:0086015 | 4 | 0.022 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.022 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.022 | |
| tissue homeostasis | GO:0001894 | 115 | 0.022 | |
| renal system development | GO:0072001 | 225 | 0.022 | Zebrafish |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.022 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.022 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.022 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.022 | Human |
| protein localization to membrane | GO:0072657 | 108 | 0.022 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.022 | |
| regulation of cardiac muscle contraction by calcium ion signaling | GO:0010882 | 9 | 0.022 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.022 | Human |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.022 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.022 | Human |
| regulation of organelle organization | GO:0033043 | 289 | 0.022 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.022 | |
| exocytosis | GO:0006887 | 121 | 0.022 | |
| synaptic transmission | GO:0007268 | 329 | 0.022 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.022 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.022 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.022 | Human |
| gland development | GO:0048732 | 330 | 0.021 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.021 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.021 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.021 | |
| hair follicle development | GO:0001942 | 85 | 0.021 | |
| protein maturation | GO:0051604 | 176 | 0.021 | |
| digestive system development | GO:0055123 | 200 | 0.021 | |
| regionalization | GO:0003002 | 337 | 0.021 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.021 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.021 | Human |
| endocytosis | GO:0006897 | 168 | 0.021 | Worm |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.021 | |
| regulation of protein localization | GO:0032880 | 231 | 0.021 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.021 | |
| protein ubiquitination | GO:0016567 | 171 | 0.021 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.020 | |
| neuromuscular process | GO:0050905 | 99 | 0.020 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.020 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.020 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.020 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.020 | |
| organic acid transport | GO:0015849 | 101 | 0.020 | |
| atp metabolic process | GO:0046034 | 75 | 0.020 | Human |
| response to uv a | GO:0070141 | 1 | 0.020 | |
| negative regulation of potassium ion transmembrane transport | GO:1901380 | 4 | 0.020 | |
| protein polymerization | GO:0051258 | 57 | 0.020 | |
| actin filament polymerization | GO:0030041 | 44 | 0.020 | |
| t cell activation | GO:0042110 | 289 | 0.019 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.019 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.019 | Human |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.019 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.019 | Human |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.019 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.019 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.019 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.019 | Human |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.019 | |
| positive regulation of transmembrane transport | GO:0034764 | 29 | 0.019 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.019 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.019 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.019 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.019 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.019 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.019 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.019 | Fly |
| mitotic cell cycle process | GO:1903047 | 159 | 0.019 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.019 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.018 | |
| membrane organization | GO:0061024 | 245 | 0.018 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.018 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.018 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.018 | Human |
| regulation of cell cycle process | GO:0010564 | 160 | 0.018 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.018 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.018 | |
| pallium development | GO:0021543 | 120 | 0.018 | |
| eating behavior | GO:0042755 | 15 | 0.018 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.018 | Human |
| myotube cell development | GO:0014904 | 60 | 0.018 | |
| stem cell differentiation | GO:0048863 | 268 | 0.018 | Zebrafish |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.018 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.018 | |
| acetate ester transport | GO:1901374 | 2 | 0.018 | |
| oocyte axis specification | GO:0007309 | 2 | 0.017 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.017 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.017 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.017 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.017 | |
| acetylcholine transport | GO:0015870 | 2 | 0.017 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.017 | Human |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.017 | |
| hexose metabolic process | GO:0019318 | 98 | 0.017 | |
| epidermis development | GO:0008544 | 187 | 0.017 | |
| cell maturation | GO:0048469 | 127 | 0.017 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.017 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.017 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.017 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.017 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.017 | |
| stem cell development | GO:0048864 | 219 | 0.017 | |
| skeletal muscle myosin thick filament assembly | GO:0030241 | 1 | 0.017 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.017 | |
| embryonic placenta development | GO:0001892 | 98 | 0.017 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 11 | 0.017 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.017 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.017 | |
| fat cell differentiation | GO:0045444 | 160 | 0.017 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.017 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.017 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.016 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.016 | |
| protein catabolic process | GO:0030163 | 221 | 0.016 | Worm |
| smooth muscle contraction | GO:0006939 | 44 | 0.016 | |
| response to fibroblast growth factor | GO:0071774 | 47 | 0.016 | |
| coagulation | GO:0050817 | 78 | 0.016 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.016 | |
| cardiac conduction | GO:0061337 | 17 | 0.016 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.016 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.016 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.016 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.016 | |
| sensory perception | GO:0007600 | 245 | 0.016 | |
| regulation of protein processing | GO:0070613 | 96 | 0.016 | |
| hemostasis | GO:0007599 | 78 | 0.016 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.016 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.016 | |
| tubulin complex assembly | GO:0007021 | 2 | 0.016 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.016 | |
| blastocyst development | GO:0001824 | 80 | 0.016 | |
| negative regulation of homeostatic process | GO:0032845 | 71 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | Human |
| response to vitamin a | GO:0033189 | 1 | 0.016 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.016 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.015 | |
| chromatin modification | GO:0016568 | 187 | 0.015 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.015 | |
| response to uv | GO:0009411 | 44 | 0.015 | |
| myoblast differentiation | GO:0045445 | 52 | 0.015 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.015 | |
| calcium ion transport | GO:0006816 | 159 | 0.015 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.015 | |
| cytokine production | GO:0001816 | 319 | 0.015 | |
| neuronal action potential | GO:0019228 | 54 | 0.015 | |
| monovalent inorganic cation homeostasis | GO:0055067 | 33 | 0.015 | |
| blastocyst formation | GO:0001825 | 33 | 0.015 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.015 | |
| multicellular organism growth | GO:0035264 | 161 | 0.015 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.015 | Human |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.015 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.015 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.015 | |
| blood coagulation | GO:0007596 | 76 | 0.015 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.015 | Human |
| mesoderm development | GO:0007498 | 100 | 0.015 | Fly |
| interleukin 8 production | GO:0032637 | 4 | 0.015 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.015 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.015 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.015 | |
| response to light stimulus | GO:0009416 | 135 | 0.014 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.014 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.014 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.014 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.014 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.014 | |
| cell communication by electrical coupling involved in cardiac conduction | GO:0086064 | 2 | 0.014 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 65 | 0.014 | |
| immune effector process | GO:0002252 | 321 | 0.014 | |
| response to metal ion | GO:0010038 | 47 | 0.014 | Human |
| homeostasis of number of cells | GO:0048872 | 210 | 0.014 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.014 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.014 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.014 | |
| mapk cascade | GO:0000165 | 281 | 0.014 | |
| respiratory system process | GO:0003016 | 25 | 0.014 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.014 | |
| plasma membrane organization | GO:0007009 | 90 | 0.014 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.014 | Human |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.014 | Human |
| chromatin organization | GO:0006325 | 206 | 0.014 | |
| organelle localization | GO:0051640 | 179 | 0.014 | |
| regulation of cell growth | GO:0001558 | 91 | 0.014 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.014 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.014 | Worm |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.014 | |
| positive regulation of cardiac muscle contraction | GO:0060452 | 2 | 0.014 | |
| cellular response to metal ion | GO:0071248 | 31 | 0.014 | |
| response to drug | GO:0042493 | 75 | 0.014 | |
| body fluid secretion | GO:0007589 | 53 | 0.014 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.013 | |
| establishment of blood nerve barrier | GO:0008065 | 3 | 0.013 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.013 | |
| tissue remodeling | GO:0048771 | 102 | 0.013 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.013 | |
| vasoconstriction | GO:0042310 | 27 | 0.013 | |
